Company Filing History:
Years Active: 2016-2018
Title: Simon Cherniak: Innovator in Pharmaceutical Chemistry
Introduction
Simon Cherniak is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel synthetic processes. With a total of 2 patents to his name, Cherniak's work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Cherniak's latest patents include innovative processes that enhance the preparation of important chemical compounds. The first patent, titled "Process for the preparation of 17-desoxy-corticosteroids," describes an improved method for synthesizing 17-desoxy corticosteroid derivatives. This process involves a single chemical step, utilizing an excess of Trimethylsilyl Iodide to react with the 17-hydroxy starting material. This invention is particularly beneficial for creating corticosteroid derivatives with halogen groups at specific positions.
The second patent, "Process for the preparation of 2-phenyl-1,3-propanediol," outlines a novel synthetic procedure that offers a simple and commercially valuable method for producing 2-phenyl-1,3-propanediol. This process involves reducing diethyl phenylmalonate with sodium borohydride in the presence of an alkali metal dihydrogen phosphate buffer, showcasing Cherniak's innovative approach to chemical synthesis.
Career Highlights
Simon Cherniak is currently associated with Taro Pharmaceutical Industries Limited, where he applies his expertise in pharmaceutical development. His work at Taro has allowed him to contribute to the advancement of drug formulations and therapeutic solutions.
Collaborations
Cherniak has collaborated with notable colleagues, including Rosa L Cyjon and Ilana Ozer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
In summary, Simon Cherniak is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborative efforts reflect his commitment to advancing the field and improving drug development processes.